K31.A1
Gastric intestinal metaplasia without dysplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Gastric intestinal metaplasia without dysplasia is a condition where the lining of the stomach gradually changes its cells to resemble those of the intestines. This transformation is considered a precancerous state, but it does not yet show signs of abnormal or uncontrolled cell growth. Often spotted during endoscopic examinations, this condition requires careful monitoring to prevent potential progression to gastric cancer. Though it might not cause symptoms directly, understanding this condition can help in managing overall gastrointestinal health.
Causes & Symptoms
Clinical Causes: Chronic infection with Helicobacter pylori bacteria Long-term gastritis (inflammation of the stomach lining) Genetic factors that predispose to mucosal changes Dietary factors such as high salt intake, smoked foods, or low fruit and vegetable consumption Exposure to environmental toxins or certain medications Autoimmune gastritis
Key Symptoms: Persistent indigestion or discomfort in the upper abdomen Nausea or feeling of fullness after meals Unintentional weight loss in some cases Occasional gastrointestinal bleeding, leading to anemia No noticeable symptoms in early stages, often found incidentally during endoscopy
Diagnostic & Treatment
Diagnosis Path: Diagnosis generally involves an endoscopic procedure where a healthcare professional visually examines the stomach lining and takes tissue samples (biopsies). The biopsies are then analyzed under a microscope to identify the presence of intestinal-type cells replacing normal stomach lining cells. This process helps determine the extent and specific characteristics of the metaplasia. Additional tests might include testing for Helicobacter pylori infection or imaging studies to rule out other gastric conditions.
Treatment Protocols: Management of gastric intestinal metaplasia focuses on addressing underlying causes and reducing cancer risk. Common approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is K31.A1 a billable ICD-10 code?
Yes, K31.A1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.A1?
Clinical documentation must specify the nature of Gastric intestinal metaplasia without dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference